文献速递妇科

转移性妇科癌症患者姑息治疗利用的种族和民族差异

Racial and ethnic disparities in palliative care utilization among gynecological cancer patients.
PubMed 文献 · Gynecol Oncol · 2020-12-02

该研究基于2016年美国国家癌症数据库,纳入124,729例18-90岁转移性妇科癌症(卵巢、宫颈、子宫)且已死亡的患者,评估姑息治疗利用的种族差异。结果显示仅7%患者利用姑息治疗,非西班牙裔黑人和西班牙裔卵巢癌患者及西班牙裔宫颈癌患者较非西班牙裔白人更少利用姑息治疗。

要点

  • 转移性妇科癌症死亡患者中仅7%利用姑息治疗,卵巢癌5%、宫颈癌11%、子宫癌12%。
  • 非西班牙裔黑人卵巢癌患者姑息治疗利用低于非西班牙裔白人(aOR 0.87, 95%CI 0.78-0.97)。
  • 西班牙裔卵巢癌和宫颈癌患者姑息治疗利用均低于非西班牙裔白人。

核心结论

  • 转移性妇科癌症患者姑息治疗利用严重不足,且存在种族和民族差异。

研究设计与样本

  • 基于2016年美国国家癌症数据库(NCDB)的回顾性队列研究,纳入124,729例18-90岁转移性(III-IV期)妇科癌症且已死亡的患者。

主要发现

  • 总体7%的转移性妇科癌症死亡患者利用姑息治疗,其中卵巢癌5%、宫颈癌11%、子宫癌12%。
  • 姑息治疗利用从2004年4%上升至2015年13%,但2016年降至7%。
  • 卵巢癌中非西班牙裔黑人(aOR 0.87, 95%CI 0.78-0.97)和西班牙裔(aOR 0.77, 95%CI 0.66-0.91)较非西班牙裔白人更少利用姑息治疗。
  • 宫颈癌中西班牙裔患者较非西班牙裔白人更少利用姑息治疗(aOR 0.75, 95%CI 0.63-0.88)。

临床怎么用

  • 临床应关注转移性妇科癌症患者姑息治疗的转诊,尤其对非西班牙裔黑人和西班牙裔患者需减少差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Palliative care (PC) is recommended for gynecological cancer patients to improve survival and quality-of-life. Our objective was to evaluate racial/ethnic disparities in PC utilization among patients with metastatic gynecologic cancer. METHODS: We used data from the 2016 National Cancer Database (NCDB) and included patients between ages 18-90 years with metastatic (stage III-IV) gynecologic cancers including, ovarian, cervical and uterine cancer who were deceased at last contact or follow-up (n = 124,729). PC was defined by NCDB as non-curative treatment, and could include surgery, radiation, chemotherapy, and pain management or any combination. We used multivariable logistic regression to evaluate racial disparities in PC use. RESULTS: The study population was primarily NH-White (74%), ovarian cancer patients (74%), insured by Medicare (47%) or privately insured (36%), and had a Charlson-Deyo score of zero (77%). Over one-third of patients were treated at a comprehensive community cancer program. Overall, 7% of metastatic gynecologic deceased cancer patients based on last follow-up utilized palliative care: more specifically, 5% of ovarian, 11% of cervical, and 12% of uterine metastatic cancer patients. Palliative care utilization increased over time starting at 4% in 2004 to as high as 13% in 2015, although palliative care use decreased to 7% in 2016. Among metastatic ovarian cancer patients, NH-Black (aOR:0.87, 95% CI:0.78-0.97) and Hispanic patients (aOR:0.77, 95% CI:0.66-0.91) were less likely to utilize PC when compared to NH-White patients. Similarly, Hispanic cervical cancer patients were less likely (aOR:0.75, 95% CI:0.63-0.88) to utilize PC when compared to NH-White patients. CONCLUSIONS: PC is highly underutilized among metastatic gynecological cancer patients. Racial disparities exist in palliative care utilization among patients with metastatic gynecological cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Islam JY, Deveaux A, Previs RA, et al. Racial and ethnic disparities in palliative care utilization among gynecological cancer patients. Gynecol Oncol. 2020. PMID: 33276985. doi:10.1016/j.ygyno.2020.11.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。